whatshot

BCAX   $21.28  5.29% Market Closed After Close 21.28 0.0

Bicara Therapeutics Inc.
show_chart Advanced Chart of BCAX

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 13
Target Price Mean 31.46
Mean unverified/preliminary 31.46 / 31.46
Target Price Low / High 16.00 / 46.00
Median / STD DEV 31.00 / 9.64
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Sell ActivelyBuy None
macd None None None
stoch None None None
ma20 Sell ActivelyBuy None
ma50 None None None
ma100 ActivelyBuy Buy ActivelyBuy
Candlestick PatternMay 27, 2026 Deliberation Block Formation - consists of three black bodies with consecutively lower closes in a downtrend. The final day is a short black candlestick, a spinning top or a doji. Considered to be a bullish reversal pattern.
ISIN US0554771032
ceo Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Website https://www.bicara.com
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.